tetano
Editor, Senior Moderator
J Infect Dis. 2018 Feb 28. doi: 10.1093/infdis/jiy103. [Epub ahead of print]
[h=1]A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.[/h] Erbelding EJ[SUP]1[/SUP], Post D[SUP]2[/SUP], Stemmy E[SUP]2[/SUP], Roberts PC[SUP]2[/SUP], Augustine AD[SUP]3[/SUP], Ferguson S[SUP]3[/SUP], Paules CI[SUP]4[/SUP], Graham BS[SUP]5[/SUP], Fauci AS[SUP]6[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] A priority for the National Institute of Allergy and Infectious Diseases (NIAID) is development of an influenza vaccine providing durable protection against multiple influenza strains, including those that may cause a pandemic, i.e., a universal influenza vaccine. To invigorate research efforts, NIAID developed a strategic plan focused on knowledge gaps in three major research areas, as well as additional resources required to ensure progress towards a universal influenza vaccine. NIAID will use this plan as a foundation for future investments in influenza research and will support and coordinate a consortium of multidisciplinary scientists focused on accelerating progress towards this goal.
PMID: 29506129 DOI: 10.1093/infdis/jiy103
[h=1]A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.[/h] Erbelding EJ[SUP]1[/SUP], Post D[SUP]2[/SUP], Stemmy E[SUP]2[/SUP], Roberts PC[SUP]2[/SUP], Augustine AD[SUP]3[/SUP], Ferguson S[SUP]3[/SUP], Paules CI[SUP]4[/SUP], Graham BS[SUP]5[/SUP], Fauci AS[SUP]6[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] A priority for the National Institute of Allergy and Infectious Diseases (NIAID) is development of an influenza vaccine providing durable protection against multiple influenza strains, including those that may cause a pandemic, i.e., a universal influenza vaccine. To invigorate research efforts, NIAID developed a strategic plan focused on knowledge gaps in three major research areas, as well as additional resources required to ensure progress towards a universal influenza vaccine. NIAID will use this plan as a foundation for future investments in influenza research and will support and coordinate a consortium of multidisciplinary scientists focused on accelerating progress towards this goal.
PMID: 29506129 DOI: 10.1093/infdis/jiy103